Min-Ho Kim Lab:Lab Members: Difference between revisions
Min-Ho Kim (talk | contribs) No edit summary |
Min-Ho Kim (talk | contribs) No edit summary |
||
| Line 69: | Line 69: | ||
<font size=3> | <font size=3> | ||
* '''Bing Yu''', Research Associate, May 2013-August 2020. | * '''Bing Yu''', Research Associate, May 2013-August 2020. | ||
* '''Jess Krieger''', Ph.D, August 2017-December 2020, Co-founder of Artemys Foods, Currently CEO and co-founder of Ohayo Valley. | * '''[https://www.kent.edu/cas/news/2020-phd-graduate-learned-how-cultivate-meat-lab-while-kent-state Jess Krieger]''', Ph.D, August 2017-December 2020 , Co-founder of Artemys Foods, Currently CEO and co-founder of Ohayo Valley. | ||
* '''Ronghui Song''', Ph.D, August 2018-May 2020, Currently at Johnson and Johnson. | * '''Ronghui Song''', Ph.D, August 2018-May 2020, Currently at Johnson and Johnson. | ||
* '''Layla Almutairi''', Ph.D, January 2015-May 2020,Currently Assistant Professor at Princess Noora bint Abdulrahman University, Riyadh, Saudi Arabia. | * '''Layla Almutairi''', Ph.D, January 2015-May 2020,Currently Assistant Professor at Princess Noora bint Abdulrahman University, Riyadh, Saudi Arabia. | ||
Revision as of 16:02, 1 February 2021
Min-Ho Kim, Ph.D.,Principal Investigator
Associate professor, Dept. of Biological Sciences, Kent State University Email: mkim15@kent.edu / Phone: 330-672-1445 Prof. Kim's department profile
|
Graduate students
|
Eric Dyne, Ph.D candidate in School of Biomedical SciencesEric has studied neurodegeneration since the beginning of his Ph.D. program after finishing his Bachelor's degree in Biological Sciences at Kent State University. The focus of his research is to develop nanotherapeutics for targeting toxic Aβ plaques and microglia via minimally invasive manner towards the treatment of AD/ADRD. |
Alhussain Ojaym, MSc, Ph.D program in School of Biomedical SciencesHussain joined Kim lab in January 2019. He is currently in the Ph.D program in the school of Biomedical Sciences at Kent State University. He has B.Sc. in Medical Laboratory and MSc. in Biomedical Sciences- specialization in Medical & Molecular Immunology. The focus of his research is to develop nanotherapeutics for targeting macrophages towards the resolution of biofilm infections.
|
Alumni
|
Undergraduate students
|
Kim Lab lunch-Novemver 2017